Literature DB >> 10411340

Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease.

A Abel1, L J Bone, A Messing, S S Scherer, K H Fischbeck.   

Abstract

X-linked Charcot-Marie-Tooth disease (CMTX) is an inherited demyelinating neuropathy caused by mutations in the gene encoding the gap junction protein connexin32 (Cx32). Despite the identification of over 160 different mutations in the Cx32 coding sequence, it is not known whether the mutations cause the disease manifestations through a loss of Cx32 function or through toxic effects on peripheral nerve. We created transgenic mice with a frameshift mutation at codon 175 (175fs), identified in a large CMTX pedigree. Light microscopic examination of the peripheral nerves from adult transgenic animals showed no pathological features. Western blotting did not show transgenic Cx32 protein in any of the 26 lines, although expression of transgenic messenger RNA was detected by reverse-transcriptase polymerase chain reaction and by ribonuclease protection assay. Our findings indicate that the 175fs mutation results in a loss of Cx32 function, without additional toxic effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411340     DOI: 10.1097/00005072-199907000-00004

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  11 in total

1.  The role of gap junctions in Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

2.  Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.

Authors:  C K Abrams; M M Freidin; V K Verselis; M V Bennett; T A Bargiello
Journal:  Brain Res       Date:  2001-05-04       Impact factor: 3.252

Review 3.  Molecular genetics of X-linked Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa; Steven S Scherer
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  X-linked Charcot-Marie-Tooth disease.

Authors:  Steven S Scherer; Kleopas A Kleopa
Journal:  J Peripher Nerv Syst       Date:  2012-12       Impact factor: 3.494

5.  Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth.

Authors:  Diane L Sherman; Lai Man N Wu; Matthew Grove; C Stewart Gillespie; Peter J Brophy
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

6.  Regulation of ubiquitin-proteasome system mediated degradation by cytosolic stress.

Authors:  Sean M Kelly; Judy K Vanslyke; Linda S Musil
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

Review 7.  How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?

Authors:  Kleopas A Kleopa; Charles K Abrams; Steven S Scherer
Journal:  Brain Res       Date:  2012-07-06       Impact factor: 3.252

8.  Schwann cell gene therapies in sight.

Authors:  Stephan Züchner
Journal:  Gene Ther       Date:  2021-06-07       Impact factor: 5.250

9.  Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury.

Authors:  Caroline Pot; Marjo Simonen; Oliver Weinmann; Lisa Schnell; Franziska Christ; Sascha Stoeckle; Philipp Berger; Thomas Rülicke; Ueli Suter; Martin E Schwab
Journal:  J Cell Biol       Date:  2002-10-14       Impact factor: 10.539

Review 10.  What's the Function of Connexin 32 in the Peripheral Nervous System?

Authors:  Mario Bortolozzi
Journal:  Front Mol Neurosci       Date:  2018-07-10       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.